Edwards Lifesciences Corporation
EWEdwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.
- Revenue
- +10.5%
- EPS
- +6.00%
- Free cash flow
- −1.84%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow EW
Alert me
Edwards Lifesciences Corporation (EW) P/E ratio
As of 13 November 2026, Edwards Lifesciences Corporation (EW) trades at a P/E ratio of 60.5×. Over the past ten years it has ranged from 9.3× (October 2024) to 77.0× (June 2021); the current reading is higher than 89% of that period. That is above the Medical Devices industry median of 25.0× and above the Healthcare sector median of 25.3×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 46.3× | 336.84% |
| FY2024 | 10.6× | (67.58%) |
| FY2023 | 32.7× | 7.92% |
| FY2022 | 30.3× | (43.37%) |
| FY2021 | 53.5× | (22.74%) |
| FY2020 | 69.3× | 49.11% |
| FY2019 | 46.5× | 4.36% |
| FY2018 | 44.5× | 10.46% |
| FY2017 | 40.3× | 12.68% |
| FY2016 | 35.8× | 3.94% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 48.8× | (6.19%) |
| Jun 2026 | 52.0× | 22.70% |
| Mar 2026 | 42.4× | (8.55%) |
| Dec 2025 | 46.3× | 38.81% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 17.4× |
| BSX Boston Scientific Corporation compare | 18.7× |
| MDT Medtronic PLC compare | 25.2× |
| PHG Koninklijke Philips N.V. compare | 25.6× |
| STE STERIS plc compare | 31.2× |
| DXCM DexCom, Inc. compare | 32.2× |
| SYK Stryker Corporation compare | 32.7× |
| ABT Abbott Laboratories compare | 40.4× |
| EW Edwards Lifesciences Corporation | 60.5× |
| Medical Devices industry median | 25.0× |
| Healthcare sector median | 25.3× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement